|[March 12, 2014]
Toshiba's Exclusive CT Myocardial Perfusion Helps Produce Faster and Safer Cardiac Diagnoses
TUSTIN, Calif. --(Business Wire)--
To improve cardiac diagnoses with simplified dose reduction technology,
Toshiba (News - Alert) announces the FDA clearance of its industry-exclusive CT
Myocardial Perfusion capability. Available on Toshiba's AquilionTM
ONE and Aquilion ONE ViSION Edition CT systems, Myocardial Perfusion
allows clinicians to visualize myocardial ischemia with CT, providing a
clinical and operational solution to make work flow.
The Myocardial Perfusion on Toshiba's 320-detector-row CTs shows blood
flow and anatomy within the coronary arteries to help determine the
viability of the heart muscle. This enables clinicians to make faster
and more accurate decisions on whether to undergo revascularization of
coronary blockages. Toshiba's CT Myocardial Perfusion puts patient
experience first with shorter exam times and significantly lower
radiation exposure, when compared with traditional coronary artery
disease (CAD) evaluation methods.
"Heart disease has remained the number one cause of death in the United
States, according to the Centers for Disease Control and Prevention, and
new CT technology is helping diagnose cardiac disease sooner," said
Satrajit Misra, senior director, CT Business Unit, Toshiba. "The
Aquilion ONE's ability to capture the entire heart in a single rotation
and its Myocardial Perfusion capability allow clinicians to make better
decisions on treatment. Additionally, Toshiba's simplified dose
reduction technology, AIDR 3D, ensures that CT dose and safety is not a
choice hospitals or patients should hve to make."
Toshiba will showcase its Myocardial Perfusion technology at this year's
American College of Cardiology (ACC) annual meeting in Washington, D.C.,
March 29-April 2, 2014 (Booth #2323).
About Toshiba America Medical Systems, Inc.
With headquarters in Tustin, Calif., Toshiba America Medical Systems
(TAMS) markets, sells, distributes and services radiology and
cardiovascular systems, including CT, MR, ultrasound, X-ray and
cardiovascular equipment, and coordinates clinical diagnostic imaging
research for all modalities in the United States. For more information,
visit the TAMS website at www.medical.toshiba.com.
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of
medical diagnostic imaging systems and comprehensive medical solutions,
such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI
systems, as well as information systems for medical institutions.
Toshiba Medical Systems Corporation has been providing medical products
for over 80 years. Toshiba Medical Systems Corporation is a wholly owned
subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation's
website at www.toshibamedicalsystems.com.
Toshiba is a world-leading diversified manufacturer, solutions provider
and marketer of advanced electronic and electrical products and systems.
Toshiba Group brings innovation and imagination to a wide range of
businesses: digital products, including LCD TVs, notebook PCs, retail
solutions and MFPs; electronic devices, including semiconductors,
storage products and materials; industrial and social infrastructure
systems, including power generation systems, smart community solutions,
medical systems and escalators & elevators; and home appliances.
Toshiba was founded in 1875, and today operates a global network of more
than 590 consolidated companies, with 206,000 employees worldwide and
annual sales surpassing 5.8 trillion yen (US$61 billion). Visit
Toshiba's website at www.toshiba.co.jp/index.htm.
[ Back To TMCnet.com's Homepage ]